Silo Pharma Stock Market Value
| SILO Stock | USD 0.95 0.04 4.40% |
| Symbol | Silo |
Silo Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Silo Pharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Silo Pharma.
| 12/03/2022 |
| 11/22/2024 |
If you would invest 0.00 in Silo Pharma on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding Silo Pharma or generate 0.0% return on investment in Silo Pharma over 720 days. Silo Pharma is related to or competes with Rezolute, Lumos Pharma, Anebulo Pharmaceuticals, Sino Biopharmaceutica, Inventiva, Biocardia, and UroGen Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic rese... More
Silo Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Silo Pharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Silo Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 23.28 | |||
| Value At Risk | (10.57) | |||
| Potential Upside | 6.31 |
Silo Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Silo Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Silo Pharma's standard deviation. In reality, there are many statistical measures that can use Silo Pharma historical prices to predict the future Silo Pharma's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.49) | |||
| Total Risk Alpha | (1.13) | |||
| Treynor Ratio | (5.77) |
Silo Pharma Backtested Returns
Silo Pharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0928, which indicates the firm had a -0.0928% return per unit of risk over the last 3 months. Silo Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Silo Pharma's Variance of 24.3, coefficient of variation of (1,040), and Risk Adjusted Performance of (0.06) to confirm the risk estimate we provide. The entity has a beta of 0.0839, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Silo Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Silo Pharma is expected to be smaller as well. At this point, Silo Pharma has a negative expected return of -0.47%. Please make sure to validate Silo Pharma's jensen alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Silo Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.29 |
Poor predictability
Silo Pharma has poor predictability. Overlapping area represents the amount of predictability between Silo Pharma time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Silo Pharma price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current Silo Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.29 | |
| Spearman Rank Test | 0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 0.15 |
Silo Pharma lagged returns against current returns
Autocorrelation, which is Silo Pharma otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Silo Pharma's otc stock expected returns. We can calculate the autocorrelation of Silo Pharma returns to help us make a trade decision. For example, suppose you find that Silo Pharma has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Silo Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Silo Pharma otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Silo Pharma otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Silo Pharma otc stock over time.
Current vs Lagged Prices |
| Timeline |
Silo Pharma Lagged Returns
When evaluating Silo Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Silo Pharma otc stock have on its future price. Silo Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Silo Pharma autocorrelation shows the relationship between Silo Pharma otc stock current value and its past values and can show if there is a momentum factor associated with investing in Silo Pharma.
Regressed Prices |
| Timeline |
Pair Trading with Silo Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Silo Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against Silo OTC Stock
| 0.41 | GRTX | Galera Therapeutics | PairCorr |
| 0.4 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
| 0.36 | GMNI | Gemini Group Global | PairCorr |
The ability to find closely correlated positions to Silo Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Silo Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Silo Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Silo Pharma to buy it.
The correlation of Silo Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Silo Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Silo Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Silo Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Silo OTC Stock
Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.